Sign In
Get Clay Free →

Suggestions

    Gregg Davis

    Vice President of Corporate Development at Seed Therapeutics

    Gregg Davis is a highly accomplished biopharma executive with a strong background in deal sourcing, analysis, negotiation, and closure across various transactions in the pharmaceutical industry.

    He holds a robust record of successful deals including gene therapy, drug licensing, R&D collaborations, acquisitions, and divestments.

    With extensive experience, Gregg has established a wide network within biopharma companies, investment banks, and venture capital firms.

    His achievements include closing multiple high-value deals, leading billion-dollar transactions, securing rights to key pharmaceutical products, and successfully negotiating complex agreements.

    Gregg's expertise lies in selling organizational capabilities, creative deal structuring, incentive alignment, negotiation, leadership, due diligence, data analysis, and strategic valuation modeling.

    He has a strong educational background, having studied at UNC Kenan-Flagler Business School and the University of North Carolina at Chapel Hill, majoring in economics and business.

    Throughout his career, Gregg has held key positions at reputable organizations including BeyondSpring, Seed Therapeutics, Asklepios BioPharmaceutical, Avadel Pharmaceuticals plc, and others.

    His professional journey includes roles in corporate development, business development, and management, showcasing his versatile skill set and leadership capabilities.

    Gregg's contributions encompass product development, launching successful pharmaceutical products, medical devices, and digital healthcare applications.

    Overall, Gregg Davis is a seasoned professional in the biopharma industry, known for his deal-making proficiency, strategic acumen, and impactful leadership.

    Gregg Davis
    Add to my network

    Location

    Raleigh, North Carolina, United States